Chadehumbe Madeline A, Greydanus Donald E, Feucht Cynthia, Patel Dilip R
Division of Pediatric Neurology, Michigan State University, Helen DeVos Children's Hospital, Grand Rapids, MI 49503, USA.
Pediatr Clin North Am. 2011 Feb;58(1):259-72, xiii. doi: 10.1016/j.pcl.2010.10.004.
Tics in children and adolescents are a common occurrence; however, a small proportion of these disorders require pharmacologic interventions. Several limitations exist with the use of pharmacologic interventions, and hence, a more ideal multidisciplinary approach is recommenced, with emphasis on nonpharmacologic management for improved functioning, adaptation, and comorbidities. Mutual and realistic goals ensure a trustful and successful relationship between the clinician and patient. An individualized plan is recommended with the goal of limiting side effects and managing comorbid conditions as a priority before addressing the tics specifically. This article reviews medications used to treat tic disorders in children and adolescents.
儿童和青少年的抽动症很常见;然而,这些病症中一小部分需要药物干预。药物干预存在一些局限性,因此,建议采用更理想的多学科方法,重点是进行非药物管理以改善功能、适应能力和共病情况。相互且现实的目标可确保临床医生与患者之间建立信任且成功的关系。建议制定个性化计划,目标是在专门治疗抽动症之前,优先限制副作用并管理共病情况。本文综述了用于治疗儿童和青少年抽动症的药物。